C-reactive protein and procalcitonin levels in prostate cancer.

Ilktac A., Kalkan S., Çalışkan S.

International journal of clinical practice, cilt.75, sa.4, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 75 Sayı: 4
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1111/ijcp.13935
  • Dergi Adı: International journal of clinical practice
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, CINAHL, EMBASE, International Pharmaceutical Abstracts, MEDLINE
  • Bezmiâlem Vakıf Üniversitesi Adresli: Evet

Özet

Aim Prostate cancer (PCa) is one of the most common cancers among men in the world. Prostate-specific antigen is the most used biomarker for PCa diagnosis. In this study, we aimed to measure the procalcitonin (PCT) and C-reactive protein (CRP) levels in patients with PCa.